- Butte, Atul;
- Mazur, PK;
- Reynoird, N;
- Khatri, P;
- Jansen, PWTC;
- Wilkinson, AW;
- Liu, S;
- Barbash, O;
- Van, GS;
- Huddleston, M;
- Dhanak, D
Deregulation of lysine methylation signalling has emerged as a common aetiological factor in cancer pathogenesis, with inhibitors of several histone lysine methyltransferases (KMTs) being developed as chemotherapeutics. The largely cytoplasmic KMT SMYD3 (S
